Together, across this cohort of datasets spanning multiple cancer types (Table S1A), while an enriched PD-L1 gene signature (and gene expression of many immune checkpoints analyzed) did not associate strongly with an epithelial program in either direction (positive or negative), they showed a predominant positive correlation with a mesenchymal signature. Here, CD274 is linked to cancer.